185 related articles for article (PubMed ID: 9353367)
1. Benzyl-polyamines: novel, potent N-methyl-D-aspartate receptor antagonists.
Igarashi K; Shirahata A; Pahk AJ; Kashiwagi K; Williams K
J Pharmacol Exp Ther; 1997 Nov; 283(2):533-40. PubMed ID: 9353367
[TBL] [Abstract][Full Text] [Related]
2. Anthraquinone polyamines: novel channel blockers to study N-methyl-D-aspartate receptors.
Kashiwagi K; Tanaka I; Tamura M; Sugiyama H; Okawara T; Otsuka M; Sabado TN; Williams K; Igarashi K
J Pharmacol Exp Ther; 2004 Jun; 309(3):884-93. PubMed ID: 14764657
[TBL] [Abstract][Full Text] [Related]
3. N1-dansyl-spermine and N1-(n-octanesulfonyl)-spermine, novel glutamate receptor antagonists: block and permeation of N-methyl-D-aspartate receptors.
Chao J; Seiler N; Renault J; Kashiwagi K; Masuko T; Igarashi K; Williams K
Mol Pharmacol; 1997 May; 51(5):861-71. PubMed ID: 9145925
[TBL] [Abstract][Full Text] [Related]
4. Antagonist properties of polyamines and bis(ethyl)polyamines at N-methyl-D-aspartate receptors.
Igarashi K; Williams K
J Pharmacol Exp Ther; 1995 Mar; 272(3):1101-9. PubMed ID: 7891322
[TBL] [Abstract][Full Text] [Related]
5. Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: Implications for studies of synaptic transmission.
Frizelle PA; Chen PE; Wyllie DJ
Mol Pharmacol; 2006 Sep; 70(3):1022-32. PubMed ID: 16778008
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotection by tosyl-polyamine derivatives through the inhibition of ionotropic glutamate receptors.
Masuko T; Namiki R; Nemoto Y; Miyake M; Kizawa Y; Suzuki T; Kashiwagi K; Igarashi K; Kusama T
J Pharmacol Exp Ther; 2009 Nov; 331(2):522-30. PubMed ID: 19644042
[TBL] [Abstract][Full Text] [Related]
7. Cyclophane and acyclic cyclophane: novel channel blockers of N-methyl-D-aspartate receptor.
Masuko T; Nagaoka H; Miyake M; Metori K; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2007 Jan; 50(2):443-9. PubMed ID: 17113196
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of linear and cyclic polyamines on NMDA receptor activities.
Masuko T; Miyake M; Kusama-Eguchi K; Koike T; Kimura E; Kizawa Y; Kashiwagi K; Igarashi K; Kusama T
Neurochem Int; 2008 Jul; 53(1-2):38-44. PubMed ID: 18556092
[TBL] [Abstract][Full Text] [Related]
9. Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol.
Ilyin VI; Whittemore ER; Guastella J; Weber E; Woodward RM
Mol Pharmacol; 1996 Dec; 50(6):1541-50. PubMed ID: 8967976
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of NMDA receptors by butanesulfonyl-homospermine guanidine and neuroprotective effects in in vitro and in vivo.
Masuko T; Suzuki T; Miyake M; Kusama-Eguchi K; Kizawa Y; Tomono K; Kashiwagi K; Igarashi K; Kusama T
Neurosci Lett; 2012 Jan; 506(2):251-5. PubMed ID: 22119002
[TBL] [Abstract][Full Text] [Related]
11. Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
Williams K
Mol Pharmacol; 1993 Oct; 44(4):851-9. PubMed ID: 7901753
[TBL] [Abstract][Full Text] [Related]
12. Pharmacology of delta2 glutamate receptors: effects of pentamidine and protons.
Williams K; Dattilo M; Sabado TN; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2003 May; 305(2):740-8. PubMed ID: 12606689
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of the N-methyl-D-aspartate receptor to polyamines is controlled by NR2 subunits.
Williams K; Zappia AM; Pritchett DB; Shen YM; Molinoff PB
Mol Pharmacol; 1994 May; 45(5):803-9. PubMed ID: 8190097
[TBL] [Abstract][Full Text] [Related]
14. Glycine modulates ethanol inhibition of heteromeric N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
Buller AL; Larson HC; Morrisett RA; Monaghan DT
Mol Pharmacol; 1995 Oct; 48(4):717-23. PubMed ID: 7476899
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of anthraquinone- and anthracene-tetraamines as blockers of N-methyl-D-aspartate receptors.
Jin L; Sugiyama H; Takigawa M; Katagiri D; Tomitori H; Nishimura K; Kaur N; Phanstiel O; Kitajima M; Takayama H; Okawara T; Williams K; Kashiwagi K; Igarashi K
J Pharmacol Exp Ther; 2007 Jan; 320(1):47-55. PubMed ID: 17050777
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
Sharma TA; Reynolds IJ
J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of conantokin-R, a selective NMDA receptor antagonist isolated from the venom of the fish-hunting snail Conus radiatus.
White HS; McCabe RT; Armstrong H; Donevan SD; Cruz LJ; Abogadie FC; Torres J; Rivier JE; Paarmann I; Hollmann M; Olivera BM
J Pharmacol Exp Ther; 2000 Jan; 292(1):425-32. PubMed ID: 10604979
[TBL] [Abstract][Full Text] [Related]
18. NR1 and NR2 subunit contributions to N-methyl-D-aspartate receptor channel blocker pharmacology.
Monaghan DT; Larsen H
J Pharmacol Exp Ther; 1997 Feb; 280(2):614-20. PubMed ID: 9023271
[TBL] [Abstract][Full Text] [Related]
19. Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine.
Williams K
Mol Pharmacol; 1994 Sep; 46(3):531-41. PubMed ID: 7935335
[TBL] [Abstract][Full Text] [Related]
20. State-dependent NMDA receptor antagonism by Ro 8-4304, a novel NR2B selective, non-competitive, voltage-independent antagonist.
Kew JN; Trube G; Kemp JA
Br J Pharmacol; 1998 Feb; 123(3):463-72. PubMed ID: 9504387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
